MIRA INFORM REPORT

 

 

Report No. :

321734

Report Date :

13.05.2015

           

IDENTIFICATION DETAILS

 

Name :

PLIVA HRVATSKA D.O.O.

 

 

Registered Office :

Prilaz baruna Filipovića 25 HR 10000 Zagreb

 

 

Country :

Croatia

 

 

Financials (as on) :

31.12.2013

 

 

Date of Incorporation :

2003

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

  • Manufacture of pharmaceutical preparations
  • Manufacture of other inorganic basic chemicals

 

 

No. of Employee :

1897 (2013)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

Croatia

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

CROATIA ECONOMIC OVERVIEW

 

Though still one of the wealthiest of the former Yugoslav republics, Croatia's economy suffered badly during the 1991-95 war. The country's output during that time collapsed and Croatia missed the early waves of investment in Central and Eastern Europe that followed the fall of the Berlin Wall. Between 2000 and 2007, however, Croatia's economic fortunes began to improve with moderate but steady GDP growth between 4% and 6% led by a rebound in tourism and credit-driven consumer spending. Inflation over the same period remained tame and the currency, the kuna, stable. Croatia experienced an abrupt slowdown in the economy in 2008 and has yet to recover; economic growth was stagnant or negative in each year since 2009. Difficult problems still remain, including a stubbornly high unemployment rate, uneven regional development, and a challenging investment climate. Croatia continues to face reduced foreign investment. On 1 July 2013 Croatia joined the EU, following a decade-long application process. Croatia will be a member of the European exchange rate Mechanism until it meets the criteria for joining the Economic and Monetary Union and adopts the euro as its currency. EU accession has increased pressure on the government to reduce Croatia’s relatively high public debt, which triggered the EU’s excessive deficit procedure for fiscal consolidation. Zagreb has cut spending since 2012, and the government also raised additional revenues through more stringent tax collection and by raising the Value Added Tax. The government has also sought to accelerate privatization of non-strategic assets, with mixed success.

 

Source : CIA

 

 

Company identification

 

PLIVA HRVATSKA d.o.o. za razvoj, proizvodnju i prodaju lijekova i farmaceutskih proizvoda

Phone

+385 1/3720000

Prilaz baruna Filipovica 25

Fax

+385 1/3720111

HR 10000 Zagreb

E-Mail

info@pliva.hr

 

Web

www.pliva.hr

 

 

Company summary

 

 Legal form                   Limited Liability Company

 

Established                   2003

 

Registered                    2003-09-16, Commercial court Zagreb, MBS: 080469030

last court entry: 2015.02.18

According to the decission from 2005.05.25 one part of the company assets is separated and taken over by the company GLOBALNI SERVISI - IT d.o.o.

(MBS: 080506104)

 

According to the court register entry from 2007.06.28 , the company PLIVA ISTRAŽIVANJE IRAZVOJ d.o.o. (MBS: 080492227) with a legal site in Zagreb, Prilaz baruna Filipovića 29 was affiliated by transfering its assets to the company PLIVA HRVATSKA d.o.o.

 

According to the court register entry from 2007.12.20 , the company GLOBALNI POSLOVNI SERVISI-IT d.o.o. (MBS:080506104) with a legal site in Zagreb was affiliated by transfering its assets to the company PLIVA HRVATSKA d.o.o.

 

According to the court register entry from 2008.11.30, the company PHARMAING d.o.o. (MBS: 080477512) with a legal site in Zagreb, Jagićeva 31, the company PUNCTUM STUDIO d.o.o. (MBS: 080477711) with a legal site in Zagreb, Gregorčićeva 8 and the company PLIVA-ESOP d.o.o. (MBS: 080171686) with a legal site in Zagreb, Grada Vukovara 49 were affiliated by transfering its assets to the company PLIVA HRVATSKA d.o.o.

 

According to the court register entry from 2010.12.31, the company PLIVA Farmaceutika d.d. (MBS: 080022035) with a legal site in Zagreb, Prilaz baruna Filipovića 25 was affiliated by transfering its assets to the company PLIVA HRVATSKA d.o.o.

 

According to the court register entry from 2011.05.22, the company TEVA PHARMACEUTICALS d.o.o. (MBS: 080680817, OIB: 60628553658) with a legal site in Zagreb, Prilaz baruna Filipovića 25 was affiliated by transfering its assets to the company PLIVA HRVATSKA d.o.o.

 

According to the court register entry from 2013.08.02, the company PLIVA ZDRAVLJE d.o.o. (MBS: 080345413, OIB 68719779759) with a legal site in Zagreb, Prilaz baruna Filipovića 25 was affiliated by transfering its assets to the company PLIVA HRVATSKA d.o.o. Statistic number: 1758705

OIB: 44205501677

 

Establishers                              Ivax International B.V.

Computerweg 10, Utrecht, Netherlands                           100,00%

 

Basic capital                             HRK 3.142.360.000,00

 

Capital changes:

Until 2003.12.22: HRK 20.000,00

Until 2005.05.25: HRK 3.030.000.000,00

Until 2005.11.02: HRK 3.013.000.000,00

Until 2008.11.30: HRK 3.138.000.000,00

 

 

Management                             Tihomir Orešković, president

Ivana Oršanića 14, 10000 Zagreb, Croatia

Zoran Bunčić, member, born 1962.06.22

Kuzminečka 6, 10000 Zagreb, Croatia

Nikolina Dizdar Čehulić, member

Ulica Vojina Bakića 1, 10000 Zagreb, Croatia

Romana Šantar, member

Drežnik IV. Odvojak 8 A, 10251 Desprim, Croatia

 

Supervisory board                     Hubert Puech Pays d Alissac, president

France

Eric Drape, vice-president

France

Maciej Mikucki, member

Poland

 

Activity                                                 Manufacture of pharmaceutical preparations

Manufacture of other inorganic basic chemicals

Manufacture of other chemical products n.e.c.

Technical testing and analysis

Other research and experimental development on natural sciences and engineering

Manufacture and distribution of pharmaceuticals

Research and development of new pharmaceuticals

After taking over production and distribution from PLIVA d.d., PLIVA HRVATSKA became the

largest pharmaceutical company and biggest exporter in Croatia

Exports all over the world: Belarus, Czech Republic, Germany, Switzerland, France, Great

 

Britan, Italy, Hungary, Macedonia, Bosnia and Hercegovina, Slovenia, USA etc.

Brands: Andol, Andol 100, Atrocam, Betrion, Cilazil, Diklonat, Gastal, Geokorton, Geonistin, Heptanon, Homofan, Homolong, Homorap, Izosan, Ketocef, Klavocin, Mirocef, Novocef, Oikamid, Peptoran, Phemiton, Plibex, Plivadial, Plivadon, Plivasept, Plivit C, Sinersul, Sumamed, Supremin, Zinidil, Tonocardin, Ulzol, Aviomarin, Diaspam, Enerbol, Flegamina, Hepatil, Lecitan, Sedamin, Venotrex, Mukolina etc.

 

legal site and business premises (production facilities) are located at the above address

facilities in Savski Marof, Prudnička cesta 54

business units:

- Dubrovačka 6, 51000 Rijeka

- Dražanac 72, 21000 Split

- Sjenjak 58, 31000 Osijek

former company address was till 2009-11-16 at Ulica grada Vukovara 49, 10000 Zagreb

the company owns vehicles, number and type not known

Book value of vehicles 2013.12.31: HRK 1.848.198,00

Basic activity code (according to NACE Rev.2):

Manufacture of pharmaceutical preparations (21.20)

 

Staff                                         2009 2395 employees

2010 1914 employees

2011 1745 employees

2012 1783 employees

2013 1897 employees

 

 

Total revenue                            2009 HRK 2.882.538.000

2010 HRK 2.795.442.600

2011 HRK 2.760.460.300

2012 HRK 3.316.678.770

2013 HRK 3.097.640.280

 

Real estate                                the company owns real estates

Book value of ground 2013.12.31: HRK 248.339.113,00

Book value of buildings 2013.12.31: HRK 894.331.722,00

information about eventual mortgage existance not available

insight into real estate register not possible

 

 


financial statement

 

ASSETS

 

Currency: HRK ( x 1.000 )

2013.12.31

2012.12.31

2011.12.31

FIXED ASSETS

4.790.624

4.323.932

3.680.490

Intangible assets

39.958

39.459

39.190

Tangible assets

2.400.305

2.035.347

1.505.386

- land and woods

248.339

248.339

248.339

- buildings

894.332

851.659

876.974

- plants and machinery

492.897

329.595

239.632

- tools, equipment, vehicles

9.209

9.530

10.847

- advance payments for tang. assets

84.969

136.921

20.217

- tangible assets in preparement

669.963

458.713

108.791

- other tangible assets

596

589

588

Long term financ. assets

1.702.863

1.701.197

1.703.527

- shares in associated companies

215.551

215.576

219.233

- other participations

56.198

51.611

51.228

- credits, deposits, guarantees

7.786

9.124

8.405

Long term receivables

647.498

547.930

432.387

CURRENT ASSETS

3.094.640

3.540.097

4.465.828

Inventories

917.422

973.326

877.312

- raw and auxiliary materials

336.906

495.640

397.729

- goods in course of production

201.380

153.240

159.954

- trade goods

124.452

96.897

104.582

- finished products

251.719

225.769

213.784

- advance payments

2.965

1.781

1.262

Short term receivables

1.298.925

1.579.725

1.554.671

- from associated companies

493.766

566.820

877.628

- from sales

733.160

773.954

515.729

- from staff

1.152

7.089

5.378

- from state and institutions

69.327

221.140

144.991

- others

1.520

10.721

10.945

Short term financial assets

829.450

688.160

1.878.647

Cash at bank and in hand

48.843

298.886

155.198

ACCRUALS

6.870

7.243

3.439

TOTAL ASSETS

7.892.133

7.871.273

8.149.757

 

LIABILITIES

 

Currency: HRK ( x 1.000 )

2013.12.31

2012.12.31

2011.12.31

EQUITY

4.186.784

3.744.608

3.059.627

Subscribed capital

3.142.360

3.142.360

3.142.360

Reserves

1.742.737

1.736.422

1.728.124

Loss brought forward

1.134.160

1.810.858

2.228.524

Profit of the period

435.846

676.684

417.666

PROVISIONS

9.123

7.938

7.179

LONG TERM LIABILITIES

2.821.173

2.787.228

2.759.597

SHORT TERM LIABILITIES

625.792

1.108.028

2.128.606

To associated companies

373.927

660.336

1.787.005

Deposits, advances payments

59

284

1.532

To suppliers

219.432

362.228

300.821

To staff

16.408

15.326

13.994

Taxes, fees, etc.

14.419

66.926

22.338

Other tax liabilities

0

1.285

1.285

Other short term liabilities

1.547

1.643

1.632

DEFFERED ITEMS

249.262

223.471

194.749

TOTAL EQUITY AND LIABILITIES

7.892.133

7.871.273

8.149.757

 

PROFIT / LOSS ACCOUNT

 

Currency: HRK ( x 1.000 )

2013.12.31

2012.12.31

2011.12.31

OPERATING REVENUES

3.075.871

3.130.528

2.611.008

Sales in the country

514.226

504.169

533.246

Sales abroad

2.193.811

2.369.369

1.877.567

Other revenues

367.833

256.989

200.195

OPERATING EXPENSES

2.589.408

2.518.162

2.128.467

Decrease in inventories

66.325

191.390

90.078

Material costs

1.574.248

1.504.156

1.129.042

- raw material costs

805.039

682.720

622.566

- sold goods costs

252.252

254.238

168.524

- other external costs

516.957

567.198

337.952

Staff costs

381.965

359.441

388.053

Depreciation of fixed assets

108.265

113.224

119.649

Depreciation of current assets

54.952

0

630

Reserves for expenses and risques

403

933

0

    Other operating expenses

403.250

349.019

401.015

FINANCIAL REVENUES

21.770

186.151

149.452

FINANCIAL EXPENSES

171.954

237.376

509.608

EXTRAORDINARY REVENUES

0

0

0

EXTRAORDINARY EXPENSES

0

0

0

TOTAL REVENUES

3.097.640

3.316.679

2.760.460

TOTAL EXPENSES

2.761.362

2.755.538

2.638.075

       Profit before taxation

336.278

561.141

122.385

       Loss before taxation

0

0

0

   Taxation on profit

-99.568

-115.543

-295.280

PROFIT OF THE PERIOD

435.846

676.684

417.666

LOSS OF THE PERIOD

0

0

0

 

 

FINANCIAL RATIOS

 

 

2013.12.31

2012.12.31

2011.12.31

Financial stability ratio

1,2293

1,2346

1,2783

Solvency ratio (%)

53,0501

47,5731

37,5426

Debt ratio (in years)

6,3350

4,9313

9,0975

Liquidity ratio

3,4791

2,3165

1,6859

Current ratio

4,9452

3,1950

2,0980

Total assets turnover

0,3925

0,4214

0,3387

Inventories turnover

3,3765

3,4076

3,1465

Collection period (in days)

172,6760

197,9096

232,1547

Creditors Days

29,1708

45,3803

44,9208

Inventories bonding (in days)

106,6205

105,6471

114,4130

Profit margin (%)

14,0703

20,4024

15,1303

Return on total assets (%)

5,5225

8,5969

5,1249

Return on equity (%)

10,4100

18,0709

13,6509

Total revenue per employee (x 1.000)

1.632,9153

1.860,1676

1.581,9257

Profit per employee (x 1.000)

229,7554

379,5197

239,3501

Equity per employee (x 1.000)

2.207,0552

2.100,1726

1.753,3676

Total assets per employee (x 1.000)

4.160,3234

4.414,6232

4.670,3477

Staff costs/Turnover (%)

12,3309

10,8374

14,0576

EBIT (x 1.000)

486.462,4500

612.365,4300

482.541,3900

EBITDA (x 1.000)

649.679,2500

725.589,1600

602.820,1000

EBIT Margin (%)

15,8154

19,5611

18,4810

EBITDA Margin (%)

21,1218

23,1779

23,0876

 

 

Remarks                       2009 import HRK 945.343.836,00

2010 import HRK 917.405.396,00

2011 import HRK 1.349.410.399,00

2012 import HRK 1.705.214.215,00

2013 import HRK 1.558.424.783,00

 

 

2009 export HRK 2.021.901.704,00

2010 export HRK 1.911.703.953,00

2011 export HRK 1.877.567.011,00

2012 export HRK 2.369.369.127,00

2013 export HRK 2.193.811.319,00

 

2009 loss HRK 183.888.000

2010 profit HRK 669.646.330

2011 profit HRK 122.385.480

2012 profit HRK 561.140.780

2013 profit HRK 336.277.790

 

Subsidiaries:

MEDIKA, d.d.                                                                    25,32%

(Statistic number: 3209741) Capraska 1, 10000 Zagreb, Croatia       

PLIVA d.o.o. Sarajevo                                                        100,00%

(Statistic number: 4201418590009)

ul. Trg Heroja broj 10, 71120 Sarajevo-Novo Sarajevo,

Bosnia & Hercegovina

ASPERA NEKRETNINE d.o.o.                                            100,00%

(Statistic number: 2764741)

PRILAZ BARUNA FILIPOVICA 25, 10000 ZAGREB, Croatia

TEVA Serbia d.o.o.                                                            100,00% Republic Serbia

PLIVA SKOPJE d.o.o.e.l.                                                   100,00%

Macedonia

PLIVA London Ltd.                                                             100,00% United Kingdom

TEVA Services Holding Ltd.                                               4,32% Hungary

Short company name: PLIVA HRVATSKA d.o.o. Translation: PLIVA CROATIA Ltd.

Investments in:

- 2008: HRK 192.743.450,00

- 2009: HRK 75.862.293,00

- 2010: HRK 97.523.364,00

- 2011: HRK 175.026.354,00

- 2012: HRK 536.829.075,00

- 2013: HRK 533.321.427,00

There is no record of payment complaints. Creditreform debt collection department has not handled any case against the company. According to the official information from the Register of transaction accounts, the company accounts are active and are not blocked (date of last check: 2015.05.08).

Exchange rate:

2010-12-31         EUR 1 = HRK 7,3852

2011-12-31         EUR 1 = HRK 7,5304

2012-12-31         EUR 1 = HRK 7,5456

12-31                 EUR 1 = HRK 7,6376

2014-12-31        EUR 1 = HRK 7,6615

 

Inflation:

2010: 1,1%

2011: 2,3%

2012: 3,4%

2013: 2,2%

2014: -0,6%

 

Bankers                                    ERSTE&STEIERMÄRKISCHE BANK d.d.

Jadranski trg 3a, 51000 Rijeka, Croatia

HR7924020061100430432

 

RAIFFEISENBANK AUSTRIA d.d.

Petrinjska 59, 10000 Zagreb, Croatia

HR6524840081101874074

 

ZAGREBACKA BANKA d.d.

Paromlinska 2, 10000 Zagreb, Croatia

HR8923600001101683058

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.64.20

UK Pound

1

Rs.100.03

Euro

1

Rs.71.91

 

 

INFORMATION DETAILS

 

Analysis Done by :

RAS

 

 

Report Prepared by :

ANK

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.